2023•Annals of OncologyOpen access

SY17-1 Evidence and clinical practice of peptide receptor radionuclide therapy for unresectable neuroendocrine tumors

Noritoshi Kobayashi, Tumugi Jono, MOTOKAZU SATO, Yuma Takeda, Naoki Okubo, Risa Fukui, Akihiro Suzuki, Motohiko Tokuhisa, Yasushi Ichikawa

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Radionuclide therapy, Medicine, Neuroendocrine tumors, Peptide receptor, Somatostatin receptor, Somatostatin, Internal medicine, Octreotide

Back to paper search Browse research topics Original source

SY17-1 Evidence and clinical practice of peptide receptor radionuclide therapy for unresectable neuroendocrine tumors — Research Paper | ScholarLens